Copyright © 2015 - 2022 Lifecarenews.in
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Celularity Announces Phase 1 Data Showing That MLASC
Early-stage data presented at the 26th Annual Meeting of the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Celularity
Celularity Inc. Announces $6 Million Registered Direct
FLORHAM PARK, N.J., April 05, 2023 (GLOBE NEWSWIRE) --…
Celularity Completes Strategic Review of 2023 Initiatives,
Commercial Biomaterials Business, Degenerative Disease Programs Continue to Gather Momentum Animal and Preclinical Data Support Significant Opportunities in Osteoarthritis for Biomaterial-Cell Therapy Combination Approach FLORHAM…
Celularity’s Placental-Derived Allogeneic Cell Therapy
Legacy studies employing a single treatment course of two infusions seven days apart demonstrated greatest benefit in three early studies Data support further investigation of novel genetically modified cell therapy in Crohn’s disease…